Q02763 (TIE2_HUMAN) Homo sapiens (Human)

Angiopoietin-1 receptor UniProtKBInterProSTRINGInteractive Modelling

1124 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; )

Sequence Features

 964Proton acceptor
 117K -> N (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation) VAR_035714
 148I -> T (in dbSNP:rs35969327) VAR_041855 dbSNP
 226A -> V (in dbSNP:rs35814893) VAR_041856 dbSNP
 233C -> Y (in GLC3E; enhanced proteasomal degradation) VAR_078046
 294K -> N (in GLC3E; unknown pathological significance; 10-fold decrease of Tyr-1102 phosphorylation; no effect on membrane location; dbSNP:rs146169480) VAR_078047 dbSNP
 346Q -> P (in dbSNP:rs682632) VAR_048002 dbSNP
 391T -> I (in dbSNP:rs34032300) VAR_048003 dbSNP
 486V -> I (in dbSNP:rs1334811) VAR_024578 dbSNP
 600V -> L (in dbSNP:rs35030851) VAR_041857 dbSNP
 611Y -> C (in GLC3E; reduced response to ligand; loss of ligand-induced phosphorylation; no effect on basal membrane location; dbSNP:rs1306527531) VAR_078048 dbSNP
 634L -> F (in dbSNP:rs35378598) VAR_041858 dbSNP
 676V -> I (in dbSNP:rs56367117) VAR_041859 dbSNP
 724A -> T (in dbSNP:rs4631561) VAR_041860 dbSNP
 849R -> W (in VMCM; increased ligand-independent autophosphorylation and kinase activation; no effect on location at membrane; dbSNP:rs80338908) VAR_006352 dbSNP
 883P -> A (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs1490428165) VAR_041861 dbSNP
 897Y -> C (in VMCM; increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs80338909) VAR_066606 dbSNP
 897Y -> F (found in a patient with multiple sporadic venous malformations; increased ligand-independent autophosphorylation; the hyperphosphorylation increases when associated with Leu-915) VAR_078049
 897Y -> H (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation) VAR_078050
 897Y -> S (in VMCM; also found in a patient with solitary sporadic venous malformations; increased ligand- independent autophosphorylation and kinase activation; dbSNP:rs80338909) VAR_008716 dbSNP
 914L -> F (found in patients with solitary and multiple sporadic venous malformations; increased ligand-independent autophosphorylation; novel location at endoplasmic reticulum and Golgi apparatus; partially retained at endoplasmic reticulum and Golgi apparatus) VAR_078051
 915R -> C (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation) VAR_078052
 915R -> H (in VMCM; strongly increased ligand- independent autophosphorylation and kinase activation; dbSNP:rs387906745) VAR_066607 dbSNP
 915R -> L (found in a patient with multiple sporadic venous malformations; increased ligand-independent autophosphorylation; the autophosphorylation increases when associated with Phe-897) VAR_078053
 917S -> I (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation) VAR_078054
 918R -> C (in VMCM; strongly increased ligand- independent autophosphorylation and kinase activation) VAR_066608
 919V -> L (in VMCM; increased ligand-independent autophosphorylation and kinase activation) VAR_066609
 925A -> S (in VMCM; increased ligand-independent autophosphorylation and kinase activation) VAR_066610
 1100K -> N (in VMCM; strongly increased ligand- independent autophosphorylation and kinase activation) VAR_066611
 1124A -> V (in a renal clear cell carcinoma sample; somatic mutation) VAR_041862
 749-769Helical
 830-838ATP
 44-102
 211-220
 224-233
 227-240
 242-251
 255-264
 268-274
 280-287
 289-298
 302-311
 315-323
 317-329
 331-340
 370-424
 19-210Missing (in GLC3E; formation of protein aggregates) VAR_078045
 24-118Tyrosine-protein kinase, receptor Tie-2, Ig-like domain 1, N-terminal
IPR018941PF10430
 449-526Fibronectin type III
IPR003961PF00041
 544-626Fibronectin type III
IPR003961PF00041
 640-722Fibronectin type III
IPR003961PF00041
 824-1091Serine-threonine/tyrosine-protein kinase, catalytic domain
IPR001245PF07714

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Structural basis for angiopoietin-1 mediated signaling initiation Heteromer
Q15389;
4k0v23-536
Angiopoietin-2/Tie2 Complex Crystal Structure Heteromer
O15123;
CA;NAG;NDG;SO4;2gy723-445
Crystal structure of the membrane proximal three fibronectin type III (FNIII) domains of Tie2 (Tie2…homo-2-mer 5utk442-735
Homodimerization of Tie2 Fibronectin-like domains 1-3 in space group C2homo-2-mer 10×NAG;BMA;MAN;5mya443-735
Homodimerization of Tie2 Fibronectin-like domains 2 and 3 in space group P21homo-2-mer NAG;BMA;5myb542-734
Tie2 Ligand-Binding Domain Crystal Structuremonomer NAG;NDG;SO4;2gy523-445
TIE2 KINASE DOMAINmonomer 1fvr813-1121
Crystal structure of cytoplasmic kinase domain of Tie2 complexed with inhibitor CEP11207monomer 0CE;3l8p814-1121
CRYSTAL STRUCTURE OF TIE2 IN COMPLEX WITH DECIPERA COMPOUND DP1919monomer SO4;919;6mwe816-1122
Structure of the Tie2 kinase domain in complex with a thiazolopyrimidine inhibitormonomer QQ1;2wqb816-1120
Synthesis, Structural Analysis, and SAR Studies of Triazine Derivatives as Potent, Selective Tie-2 …monomer RAJ;2oo8836-1117
Evolution of a highly Selective and Potent 2-(Pyridin-2-yl)-1,3,5-triazine Tie-2 Kinase Inhibitormonomer MR9;2p4i838-1117
Selection of fragments for kinase inhibitor design: decoration is keymonomer 3WR;4x3j838-1117
Synthesis, Structural Analysis, and SAR Studies of Triazine Derivatives as Potent, Selective Tie-2 …monomer MUH;2osc837-1116
cFMS tyrosine kinase (tie2 KID) in complex with a pyrimidinopyridone inhibitormonomer SO4;IXH;3bea917-935

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
3monomer-0.335mya.1.A296-588
100.00
3monomerQQ1;-2.272wqb.1.A668-972
99.69
2monomer-0.255mya.1.A400-692
100.00
2monomerQQ1;-2.122wqb.1.A773-1077
99.69
3monomer-4.834k0v.1.A20-389
99.73